Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DX25F6XRW
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $13,698
Award facts
- Contract value 100% obligated
- $13,697.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order valued at $13,697.84 from the Defense Logistics Agency's Medical Supply Chain for the supply of Xolair 300 mg/2 ml auto-injector vials. The delivery order, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, was awarded without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026, which authorizes firm fixed-price orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
The award represents a continuation of DMS Pharmaceutical Group's established role as a critical supplier in the federal pharmaceutical supply chain, particularly for the Department of Defense healthcare infrastructure. Xolair (omalizumab) is a prescribed biologic medication used in the treatment of allergic asthma and other allergic conditions, making this delivery order consistent with the contractor's portfolio of specialty pharmaceutical products and biologics. The company's consistent procurement success reflects its competitive positioning as a woman-owned small business within federal pharmaceutical procurement markets and its capability to deliver specialized medical products to support military medical supply requirements.
Quick answers
Who was awarded contract SPE2DX25F6XRW?
SPE2DX25F6XRW was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 2, 2025.
How much is contract SPE2DX25F6XRW worth?
The government has obligated $13,698 on SPE2DX25F6XRW.
Is contract SPE2DX25F6XRW an order under another contract?
Yes. SPE2DX25F6XRW is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XRW competed?
The extent of competition for SPE2DX25F6XRW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award